Scopus BioPharma Inc.
SCPS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $3 | $15 | $7 | $0 |
| G&A Expenses | $9 | $13 | $3 | $2 |
| SG&A Expenses | $9 | $13 | $3 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $12 | $28 | $10 | $3 |
| Operating Income | -$12 | -$28 | -$10 | -$3 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $1 | -$1 | $0 |
| Pre-Tax Income | -$12 | -$27 | -$11 | -$3 |
| Tax Expense | -$0 | $1 | $1 | $0 |
| Net Income | -$12 | -$28 | -$12 | -$3 |
| % Margin | – | – | – | – |
| EPS | -0.55 | -1.61 | -0.87 | -0.18 |
| % Growth | 65.8% | -85.1% | -383.3% | – |
| EPS Diluted | -0.55 | -1.61 | -0.87 | -0.18 |
| Weighted Avg Shares Out | 21 | 17 | 13 | 15 |
| Weighted Avg Shares Out Dil | 21 | 17 | 13 | 15 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$12 | -$26 | -$10 | -$3 |
| % Margin | – | – | – | – |